Fact-Checking ‘Does That Make Sense? ’: Breaking Down Ohio's Kratom Policy Proposal
Q1: Why is synthetic 7-OH considered dangerous while raw kratom leaf is considered safer?
A1: Unprocessed kratom leaf contains low concentrations of 7-OH alongside dozens of other compounds, including opioid antagonists that trigger ceiling effects and prevent extreme central nervous system depression. Synthetic 7-OH products isolate and concentrate the chemical up to hundreds of times above natural levels, dramatically increasing potency and physical dependence risks.
Q2: What is the current status of Ohio's proposed kratom legislation?
A2: Ohio lawmakers continue debating competing approaches in legislative committees. One faction seeks a full Schedule I ban through the State of Ohio Board of Pharmacy, while opposing lawmakers have introduced amendments based on the Kratom Consumer Protection Act to regulate retail purity and establish age minimums.
Q3: How does the federal government view kratom versus isolated 7-OH?
A3: Federal agencies increasingly distinguish between raw botanicals and synthetic isolates. In July 2025, the FDA urged the DEA to target synthetic and semi-synthetic 7-OH under the Controlled Substances Act, while federal research bodies continue studying natural *Mitragyna speciosa* for potential pain management and harm-reduction properties.